KALA BIO, Inc.
KALA
Rangering i aksjer
#30862
Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the... Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the creation and commercialization of new therapeutic solutions. The core of their strategy involves utilizing proprietary nanoparticle technology, specifically mucus penetrating particles (MPPs). Initially, their focus for these treatments is directed towards ophthalmic diseases. The company was established in 2009 by co-founders Justin Hanes, Robert S. Langer, and Colin R. Gardner, and its headquarters are located in Arlington, Massachusetts.
Aksjekurs
$0.75
Sist synkronisert: 2026-07-31
Markedsverdi
$14.50M
Endring (1 dag)
2.78%
Endring (1 år)
-98.84%
Land
US
Handel KALA BIO, Inc. (KALA)
Kategori
Healthcare
Markedsverdi av KALA BIO, Inc.(KALA)
Markedsverdi: $14.50M
Per October 2026 har KALA BIO, Inc. en markedsverdi på $14.50M. Dette gjør KALA BIO, Inc. til det 30862nd mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for KALA BIO, Inc. fra 2018 til 2026
KALA sammenlignet med topp 5 mest populære stocks
| Pris på KALA | Eiendel B | Markedsverdi for B | Resultater | |
|---|---|---|---|---|
$37,305,976
$28.21K
|
$5.239T | +18,569,425,244.37% | ||
|
$35,798,441
$28.21K
|
$5.027T | +17,819,034,589.91% | ||
|
$29,788,601
$28.21K
|
$4.183T | +14,827,576,498.53% | ||
|
$28,289,937
$28.21K
|
$3.973T | +14,081,600,962.44% | ||
|
$20,094,259
$28.21K
|
$2.822T | +10,002,119,910.79% |
